Annual Short Term Debt
$10.30 M
-$2.30 M-18.25%
December 1, 2024
Summary
- As of March 12, 2025, RARE annual short term debt is $10.30 million, with the most recent change of -$2.30 million (-18.25%) on December 1, 2024.
- During the last 3 years, RARE annual short term debt has fallen by -$769.00 thousand (-6.95%).
- RARE annual short term debt is now -18.25% below its all-time high of $12.60 million, reached on December 31, 2023.
Performance
RARE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$10.30 M
-$127.00 K-1.22%
December 1, 2024
Summary
- As of March 12, 2025, RARE quarterly short term debt is $10.30 million, with the most recent change of -$127.00 thousand (-1.22%) on December 1, 2024.
- Over the past year, RARE quarterly short term debt has dropped by -$2.30 million (-18.25%).
- RARE quarterly short term debt is now -19.44% below its all-time high of $12.78 million, reached on March 31, 2024.
Performance
RARE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
RARE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.3% | -18.3% |
| 3 y3 years | -7.0% | -7.0% |
| 5 y5 years | +42.3% | +42.3% |
RARE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.3% | at low | -19.4% | at low |
| 5 y | 5-year | -18.3% | +42.3% | -19.4% | +42.3% |
| alltime | all time | -18.3% | -100.0% | -19.4% | -100.0% |
Ultragenyx Pharmaceutical Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $10.30 M(-18.2%) | $10.30 M(-1.2%) |
| Sep 2024 | - | $10.42 M(-11.0%) |
| Jun 2024 | - | $11.72 M(-8.3%) |
| Mar 2024 | - | $12.78 M(+1.5%) |
| Dec 2023 | $12.60 M(+6.9%) | $12.60 M(+4.4%) |
| Sep 2023 | - | $12.07 M(+10.9%) |
| Jun 2023 | - | $10.88 M(-3.3%) |
| Mar 2023 | - | $11.26 M(-4.4%) |
| Dec 2022 | $11.78 M(+6.4%) | $11.78 M(-0.3%) |
| Sep 2022 | - | $11.82 M(+1.6%) |
| Jun 2022 | - | $11.63 M(+2.7%) |
| Mar 2022 | - | $11.32 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $11.07 M(+23.3%) | $11.07 M(+3.4%) |
| Sep 2021 | - | $10.70 M(+3.8%) |
| Jun 2021 | - | $10.30 M(+9.9%) |
| Mar 2021 | - | $9.38 M(+4.5%) |
| Dec 2020 | $8.98 M(+24.1%) | $8.98 M(+15.3%) |
| Sep 2020 | - | $7.79 M(+7.3%) |
| Jun 2020 | - | $7.26 M(-3.1%) |
| Mar 2020 | - | $7.49 M(+3.5%) |
| Dec 2019 | $7.24 M(>+9900.0%) | $7.24 M(-0.8%) |
| Sep 2019 | - | $7.29 M(+4.2%) |
| Jun 2019 | - | $7.00 M(+33.1%) |
| Mar 2019 | - | $5.26 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Ultragenyx Pharmaceutical annual short term debt?
- What is the all time high annual short term debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual short term debt year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly short term debt?
- What is the all time high quarterly short term debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly short term debt year-on-year change?
What is Ultragenyx Pharmaceutical annual short term debt?
The current annual short term debt of RARE is $10.30 M
What is the all time high annual short term debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual short term debt is $12.60 M
What is Ultragenyx Pharmaceutical annual short term debt year-on-year change?
Over the past year, RARE annual short term debt has changed by -$2.30 M (-18.25%)
What is Ultragenyx Pharmaceutical quarterly short term debt?
The current quarterly short term debt of RARE is $10.30 M
What is the all time high quarterly short term debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly short term debt is $12.78 M
What is Ultragenyx Pharmaceutical quarterly short term debt year-on-year change?
Over the past year, RARE quarterly short term debt has changed by -$2.30 M (-18.25%)